Novo Nordisk is sticking close to home for its latest GLP-1 deal, signing a $285 million partnership with fellow Danish company Ascendis Pharma to work on new therapeutics for metabolic and cardiovascular diseases
An SFRP1 inhibitor investigated at Manchester University in the context of hair
Arctiko reduces these risks with automation, integrated alarms, and audit-ready data logging, safeguarding GLP-1 therapies from human error
Some research suggests that the inflammatory cascade triggered by chronically elevated homocysteine may lower the threshold for anxiety and depressive episodes in susceptible individuals
Reversible glutathionylation of Complex I in response to oxidation of mitochondrial GSH pool has been shown to increase ROS formation [49]
If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting Sermorelin or any new prescription treatment